SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 34 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $916,770 | +80.1% | 1,034,729 | +219.1% | 0.01% | +66.7% |
Q3 2022 | $509,000 | +430.2% | 324,289 | +577.1% | 0.00% | +200.0% |
Q2 2022 | $96,000 | -86.2% | 47,893 | -84.0% | 0.00% | -83.3% |
Q1 2022 | $698,000 | +507.0% | 299,507 | +1105.8% | 0.01% | +500.0% |
Q4 2021 | $115,000 | – | 24,838 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 2,186,520 | $38,526,000 | 10.61% |
Cormorant Asset Management, LP | 1,945,334 | $34,277,000 | 4.56% |
Aisling Capital LLC | 1,703,855 | $30,022,000 | 4.47% |
Wildcat Capital Management, LLC | 736,012 | $12,968,000 | 4.44% |
ACUTA CAPITAL PARTNERS, LLC | 212,402 | $3,743,000 | 2.31% |
Healthcare Value Capital, LLC | 50,000 | $881,000 | 0.92% |
EAM Investors, LLC | 249,028 | $4,388,000 | 0.51% |
TFS CAPITAL LLC | 150,812 | $2,657,000 | 0.26% |
GAGNON SECURITIES LLC | 11,001 | $194,000 | 0.08% |
Granite Investment Partners, LLC | 43,861 | $772,000 | 0.07% |